Clinical trial
Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome
NCT00406445 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00406445 |
|---|---|
| Title | Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome |
| Official title | Metabolic Regulation by Tumor Suppressor p53 in Li-Fraumeni Syndrome |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Mitochondrial Disorders, Li-Fraumeni Syndrome, Carriers of p53 Mutation |
| Enrollment | 82 |
| Start date | Jan 23, 2007 |
| Primary completion | Mar 22, 2021 |
| Completion | Mar 22, 2021 |
| First posted | Dec 4, 2006 |
| Last update posted | Nov 22, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: